Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines

被引:27
作者
Guiso, N [1 ]
Boursaux-Eude, C
Weber, C
Hausman, SZ
Sato, H
Iwaki, M
Kamachi, K
Konda, T
Burns, DL
机构
[1] Inst Pasteur, Ctr Natl Reference Bordetelles, Unite Bordetella, Paris, France
[2] Natl Inst Infect Dis, Dept Bacterial & Blood Prod, Tokyo, Japan
[3] US FDA, Ctr Biol Evaluat & Res, Lab Resp & Special Pathogens, Bethesda, MD USA
关键词
Bordetella pertussis; acellular vaccines; Japan;
D O I
10.1016/S0264-410X(01)00013-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Because of recent concern that whole-cell pertussis vaccination can drive antigenic divergence of circulating isolates of Bordetella pertussis. we compared 12 clinical isolates of B. pertussis collected in Japan, the first country to introduce acellular pertussis vaccines, with the vaccine strain. We used pulsed-field gel electrophoresis. sequencing of ptx and pm genes and expression of fimbriae. Most of the isolates collected before or after introduction of acellular vaccine possess similar restriction patterns. They contain ptx genes and pm alleles similar to the vaccine strain and to European isolates collected before the introduction of vaccination. Two recently collected isolates exhibiting a different pulsed-field gel electrophoresis pattern possess ptxS1 and pm alleles similar to the alleles harbored by European isolates circulating currently. Our preliminary results suggest that, if acellular pertussis antigenic divergence exists, it is likely to be a slow or rare process. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3248 / 3252
页数:5
相关论文
共 22 条
[1]   CONTRIBUTION OF THE B-OLIGOMER TO THE PROTECTIVE ACTIVITY OF GENETICALLY ATTENUATED PERTUSSIS TOXIN [J].
ARCINIEGA, JL ;
SHAHIN, RD ;
BURNETTE, WN ;
BARTLEY, TD ;
WHITELEY, DW ;
MAR, VL ;
BURNS, DL .
INFECTION AND IMMUNITY, 1991, 59 (10) :3407-3410
[2]   Intranasal murine model of Bordetella pertussis infection:: II.: Sequence variation and protection induced by a tricomponent acellular vaccine [J].
Boursaux-Eude, C ;
Thiberge, S ;
Carletti, G ;
Guiso, N .
VACCINE, 1999, 17 (20-21) :2651-2660
[3]  
CASELLA JF, 1988, LANCET, V1, P1238
[4]   Acellular pertussis vaccines for infants [J].
Edwards, KM ;
Decker, MD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :391-392
[5]  
EDWARDS KM, 1993, J INFECT DIS, V168, P15, DOI 10.1093/infdis/168.1.15
[6]   CURRENT EPIDEMIOLOGY OF PERTUSSIS IN JAPAN [J].
KIMURA, M ;
KUNOSAKAI, H .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (10) :705-709
[7]   Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children [J].
Mastrantonio, P ;
Spigaglia, P ;
van Oirschot, H ;
van der Heide, HGJ ;
Heuvelman, K ;
Stefanelli, P ;
Mooi, FR .
MICROBIOLOGY-UK, 1999, 145 :2069-2075
[8]  
MING LZ, 1988, INFECT IMMUN, V56, P3184
[9]   Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland [J].
Mooi, FR ;
He, QS ;
van Oirschot, H ;
Mertsola, J .
INFECTION AND IMMUNITY, 1999, 67 (06) :3133-3134
[10]   Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands:: Temporal trends and evidence for vaccine-driven evolution [J].
Mooi, FR ;
van Oirschot, H ;
Heuvelman, K ;
van der Heide, HGJ ;
Gaastra, W ;
Willems, RJL .
INFECTION AND IMMUNITY, 1998, 66 (02) :670-675